Target intelligence / Profile preview

SRGAP3 antisense RNA 2 (SRGAP3-AS2)

Target
SRGAP3-AS2
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

SRGAP3 antisense RNA 2 is a long non-coding RNA that acts as an antisense to the SRGAP3 gene. It is involved in the regulation of gene expression and has been found to be differentially expressed in cancer samples, such as lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD), suggesting potential roles in cancer biology. Antisense RNAs like SRGAP3-AS2 can influence gene expression by interacting with their complementary mRNAs or by affecting chromatin structure and transcriptional regulation. While SRGAP3-AS2 is not typically considered a direct therapeutic target, understanding its role in modulating gene expression could provide insights into novel therapeutic strategies.

Other names
SRGAP3 antisense RNA 2 (non-protein coding)
02

Mechanism of action

Potentially affects gene expression by interacting with regulatory elements or modulating chromatin structure

03

Biological functions

Regulation of gene expressionModulating splicingModulating chromatin structure
04

Disease associations

CancerLung squamous cell carcinoma (LUSC)Lung adenocarcinoma (LUAD)

Beyond the preview

Go deeper on SRGAP3 antisense RNA 2 (SRGAP3-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SRGAP3 antisense RNA 2 (SRGAP3-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call